Paper34869239
Cyclodextrin-Appended Superparamagnetic Iron Oxide Nanoparticles as Cholesterol-Mopping Agents.
Puglisi A and 2 others. Front Chem, 2021. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Cyclodextrin-Appended Superparamagnetic Iron Oxide Nanoparticles as Cholesterol-Mopping Agents. Papers, record 34869239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34869239
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cyclodextrin-Appended Superparamagnetic Iron Oxide Nanoparticles as Cholesterol-Mopping Agents.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20861879 | Revitalizing membrane rafts: new tools and insights. | Nat Rev Mol Cell Biol | 2010 | https://conductscience.org/library/papers/20861879 | PubMed |
| 2 | 7907994 | beta-Cyclodextrin interacts with the Alzheimer amyloid beta-A4 peptide. | FEBS Lett | 1994 | https://conductscience.org/library/papers/7907994 | PubMed |
| 3 | 30216584 | Cyclodextrin-Based Macromolecular Systems as Cholesterol-Mopping Therapeutic Agents in Niemann-Pick Disease Type C. | Macromol Rapid Commun | 2019 | https://conductscience.org/library/papers/30216584 | PubMed |
| 4 | 15573101 | Cyclodextrin-based pharmaceutics: past, present and future. | Nat Rev Drug Discov | 2004 | https://conductscience.org/library/papers/15573101 | PubMed |
| 5 | 30231877 | Nano based drug delivery systems: recent developments and future prospects. | J Nanobiotechnology | 2018 | https://conductscience.org/library/papers/30231877 | PubMed |
| 6 | 22848170 | Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. | Int J Nanomedicine | 2012 | https://conductscience.org/library/papers/22848170 | PubMed |
| 7 | 21538367 | Phase solubility studies and stability of cholesterol/β-cyclodextrin inclusion complexes. | J Sci Food Agric | 2011 | https://conductscience.org/library/papers/21538367 | PubMed |
| 8 | 16018907 | 2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review. | Food Chem Toxicol | 2005 | https://conductscience.org/library/papers/16018907 | PubMed |
| 9 | 25223281 | Cholesterol in brain disease: sometimes determinant and frequently implicated. | EMBO Rep | 2014 | https://conductscience.org/library/papers/25223281 | PubMed |
| 10 | 26059798 | Pharmacokinetics of cyclodextrins and drugs after oral and parenteral administration of drug/cyclodextrin complexes. | J Pharm Pharmacol | 2016 | https://conductscience.org/library/papers/26059798 | PubMed |
| 11 | 27999408 | Cyclodextrins as Emerging Therapeutic Tools in the Treatment of Cholesterol-Associated Vascular and Neurodegenerative Diseases. | Molecules | 2016 | https://conductscience.org/library/papers/27999408 | PubMed |
| 12 | 25280844 | Comparative assessment of the stability of nonfouling poly(2-methyl-2-oxazoline) and poly(ethylene glycol) surface films: an in vitro cell culture study. | Biointerphases | 2014 | https://conductscience.org/library/papers/25280844 | PubMed |
| 13 | 27834398 | Cancer nanomedicine: progress, challenges and opportunities. | Nat Rev Cancer | 2017 | https://conductscience.org/library/papers/27834398 | PubMed |
| 14 | 21455285 | Molecular mechanism of cyclodextrin mediated cholesterol extraction. | PLoS Comput Biol | 2011 | https://conductscience.org/library/papers/21455285 | PubMed |
| 15 | 27799764 | Optimizing superparamagnetic iron oxide nanoparticles as drug carriers using an in vitro blood-brain barrier model. | Int J Nanomedicine | 2016 | https://conductscience.org/library/papers/27799764 | PubMed |
| 16 | 27046133 | Evaluation of High-Yield Purification Methods on Monodisperse PEG-Grafted Iron Oxide Nanoparticles. | Langmuir | 2016 | https://conductscience.org/library/papers/27046133 | PubMed |
| 17 | 33079457 | Investigating the Mechanism of Cyclodextrins in the Treatment of Niemann-Pick Disease Type C Using Crosslinked 2-Hydroxypropyl-β-cyclodextrin. | Small | 2020 | https://conductscience.org/library/papers/33079457 | PubMed |
| 18 | 23975334 | Poly(2-oxazoline)s as materials for biomedical applications. | J Mater Sci Mater Med | 2014 | https://conductscience.org/library/papers/23975334 | PubMed |
| 19 | 28155937 | Controlled aggregation and cell uptake of thermoresponsive polyoxazoline-grafted superparamagnetic iron oxide nanoparticles. | Nanoscale | 2017 | https://conductscience.org/library/papers/28155937 | PubMed |
| 20 | 23199200 | Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeutics. | Expert Opin Drug Deliv | 2013 | https://conductscience.org/library/papers/23199200 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37382765 | Current advances in nanodrug delivery systems for malaria prevention and treatment. | Discov Nano | 2023 | https://conductscience.org/library/papers/37382765 | PubMed |
| 36979508 | Grafting of Cyclodextrin to Theranostic Nanoparticles Improves Blood-Brain Barrier Model Crossing. | Biomolecules | 2023 | https://conductscience.org/library/papers/36979508 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34869239
GET https://conductscience.org/api/papers/v1/34869239/references?page=2